Pathway Inhibitors

Vevorisertib trihydrochloride View larger

Vevorisertib trihydrochloride

AT38846

CAS 1416775-08-0

More details

Molarity Calculation Cart®

HOW TO ORDER

$60.00

$60.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $27.00 Total: $2,700.00
150 $31.20 Total: $1,560.00
125 $36.60 Total: $915.00
110 $43.20 Total: $432.00
15 $51.00 Total: $255.00

Data sheet

Molecular FormulaC35H41Cl3N8O
Molecular Weight696.12
CAS Numbers1416775-08-0
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeCl.Cl.Cl.CN(C1CCN(CC1)c1cccc(c1)-c1ccc2nc(-c3cccnc3N)n(-c3ccc(cc3)C3(N)CCC3)c2n1)C(C)=O
ReferencesKozinova M, et al. Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 [PDCD4] in Gastrointestinal Stromal Tumor. Cancers [Basel]. 2021 Jul 23;13[15] 3699.

More info

Vevorisertib trihydrochloride (ARQ 751 trihydrochloride) is a selective and potent inhibitor of pan-AKT and AKT1-E17K mutations, inhibiting AKT1, AKT2 and AKT3. Vevorisertib trihydrochloride is used in the study of hepatocellular carcinoma and advanced solid tumours.